Mariner LLC Acquires 26,325 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Mariner LLC raised its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 21.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 149,240 shares of the pharmacy operator's stock after acquiring an additional 26,325 shares during the quarter. Mariner LLC's holdings in Walgreens Boots Alliance were worth $1,392,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. First Financial Corp IN raised its stake in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after purchasing an additional 885 shares during the period. Golden State Wealth Management LLC purchased a new position in Walgreens Boots Alliance during the 4th quarter valued at about $26,000. Riverview Trust Co increased its position in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after buying an additional 1,590 shares during the period. Venturi Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth about $28,000. Finally, Independence Bank of Kentucky bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $39,000. Hedge funds and other institutional investors own 58.59% of the company's stock.

Analyst Upgrades and Downgrades

WBA has been the topic of a number of analyst reports. Truist Financial decreased their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Royal Bank of Canada increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a research report on Wednesday, January 15th. Bank of America lifted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research note on Monday, January 13th. Evercore ISI upped their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research note on Monday, January 13th. Finally, Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their price target for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Stock Down 0.2 %

Shares of NASDAQ:WBA opened at $11.01 on Friday. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $18.83. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The stock's 50-day moving average price is $10.95 and its 200-day moving average price is $10.21. The stock has a market capitalization of $9.52 billion, a P/E ratio of -1.08, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The business had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business's quarterly revenue was up 4.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.20 EPS. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.